The head of Wal-Mart Stores Inc. (NYSE:WMT)’s health and wellness business unit has left the company. Dr. John Agwunobi, who joined the Bentonville retailer in 2007 as president for the professional services division in the U.S., departed late last month. Wal-Mart Stores, Inc. (NYSE:WMT) shares after opening at $77.58 moved to $77.90 on last trade day and at the end of the day closed at $77.31. Company price to sales ratio in past twelve months was calculated as 0.52 and price to cash ratio as 37.67. Wal-Mart Stores, Inc. (NYSE:WMT) showed a positive weekly performance of 1.71%.
Shares in Italy’s Ansaldo STS were suspended limit-down after a fall of more than 9 percent in early trading on Monday after U.S. conglomerate General Electric Company (NYSE:GE) pulled out from a race to buy the rail signalling company. GE Electric Company (NYSE:GE) Europe President and CEO Nani Beccalli-Falco said on Friday he did not see room for a deal to buy Ansaldo, which Finmeccanica has put up for sale to cut debt and focus on its core aerospace and defence businesses. General Electric Company (NYSE:GE) shares fell -0.80% in last trading session and ended the day on $26.02. General Electric Company (NYSE:GE) return on equity ratio is recorded as 10.40% and its return on assets is 2.00%. General Electric Company (NYSE:GE) yearly performance is 17.21%.
Wal-Mart Stores Inc.’s co-branded credit cards will soon carry MasterCard Inc (NYSE:MA)’s logo under a deal the retailer struck with General Electric Co.’s banking arm to switch from Discover Financial Services. Wal-Mart said its credit-card portfolio will convert to MasterCard Inc (NYSE:MA) later this summer, while credit cards marketed in the name of the retailer’s Sam’s Club division will begin switching in June, a spokeswoman for Wal-Mart said. Mastercard Inc (NYSE:MA) shares moved down -3.15% in last trading session and was closed at $72.18, while trading in range of $71.71 – $75.49. Mastercard Inc (NYSE:MA) year to date (YTD) performance is -13.48%.
Endocyte, Inc. (NASDAQ:ECYT) shares fell 4.8% following the announcement of its intention to issue shares and the pricing of the underwritten public offering of its common stock. Endocyte, Inc. (NASDAQ:ECYT) weekly performance is -0.96%. On last trading day company shares ended up $21.75. Endocyte, Inc. (NASDAQ:ECYT) distance from 50-day simple moving average (SMA50) is 38.69%. Analysts mean target price for the company is $41.94.
Leave a Reply